JP2000505104A - 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物 - Google Patents

喘息の治療のためのロラタジンおよび充血除去剤を含む組成物

Info

Publication number
JP2000505104A
JP2000505104A JP10520579A JP52057998A JP2000505104A JP 2000505104 A JP2000505104 A JP 2000505104A JP 10520579 A JP10520579 A JP 10520579A JP 52057998 A JP52057998 A JP 52057998A JP 2000505104 A JP2000505104 A JP 2000505104A
Authority
JP
Japan
Prior art keywords
loratadine
asthma
decongestant
administered
pseudoephedrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10520579A
Other languages
English (en)
Japanese (ja)
Inventor
ジー． ハリス，アラン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2000505104A publication Critical patent/JP2000505104A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP10520579A 1996-10-31 1997-10-29 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物 Pending JP2000505104A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
US08/739,669 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
JP2000505104A true JP2000505104A (ja) 2000-04-25

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10520579A Pending JP2000505104A (ja) 1996-10-31 1997-10-29 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物

Country Status (21)

Country Link
EP (1) EP0941091A1 (pt)
JP (1) JP2000505104A (pt)
KR (1) KR20000052922A (pt)
CN (1) CN1235545A (pt)
AR (1) AR008908A1 (pt)
AU (1) AU731756B2 (pt)
BR (1) BR9712705A (pt)
CA (1) CA2268546A1 (pt)
CO (1) CO4910128A1 (pt)
CZ (1) CZ150999A3 (pt)
HU (1) HUP9904075A3 (pt)
ID (1) ID23431A (pt)
IL (1) IL129662A0 (pt)
NO (1) NO992062L (pt)
NZ (1) NZ335078A (pt)
PE (1) PE11399A1 (pt)
PL (1) PL333056A1 (pt)
SK (1) SK54599A3 (pt)
TR (1) TR199901003T2 (pt)
WO (1) WO1998018470A1 (pt)
ZA (1) ZA979731B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270796B1 (en) * 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
PA8481801A1 (es) * 1998-09-10 2000-09-29 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
PA8517201A1 (es) * 2000-05-25 2002-08-26 Schering Corp Composiciones farmaceuticas antihistaminicas anticongestivas liquidas estables
CA2450583A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
NZ588134A (en) 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
JP5175278B2 (ja) * 2006-06-01 2013-04-03 エムエスディー コンシューマー ケア， インコーポレイテッド 結腸吸収のためのフェニレフリン薬学的製剤および組成物
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
BR9712705A (pt) 1999-10-26
NO992062D0 (no) 1999-04-29
PL333056A1 (en) 1999-11-08
CN1235545A (zh) 1999-11-17
IL129662A0 (en) 2000-02-29
WO1998018470A1 (en) 1998-05-07
CZ150999A3 (cs) 1999-10-13
AU731756B2 (en) 2001-04-05
ZA979731B (en) 1998-04-29
CA2268546A1 (en) 1998-05-07
AU4995397A (en) 1998-05-22
HUP9904075A2 (hu) 2000-05-28
SK54599A3 (en) 2000-08-14
EP0941091A1 (en) 1999-09-15
HUP9904075A3 (en) 2002-02-28
TR199901003T2 (xx) 1999-07-21
PE11399A1 (es) 1999-02-09
AR008908A1 (es) 2000-02-23
ID23431A (id) 2000-04-20
CO4910128A1 (es) 2000-04-24
NO992062L (no) 1999-04-29
KR20000052922A (ko) 2000-08-25
NZ335078A (en) 2000-10-27

Similar Documents

Publication Publication Date Title
JP2000505104A (ja) 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物
TWI296525B (en) Novel combination of nonsedating antihistamines with substances which influence leukotriene action, for the treatment of rhinitis/conjunctivitis
EP1446119B1 (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JP2007518755A (ja) モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
KR101841442B1 (ko) 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
ZA200500152B (en) Use of reboxetine for the treatment of hot flashes
JPH07509476A (ja) 高眼内圧の治療または予防のための医薬
CA2420532A1 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
Davies et al. Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis
JP2003521515A (ja) アレルギー状態および炎症状態の処置
IE913580A1 (en) Medicaments
Von Berg et al. Efficacy and tolerability of formoterol Turbuhaler® in children
JP2002514601A (ja) Ｎ．ａ．ｒ．ｉ．、好ましくはレボキセチンおよびピンドロールの新しい薬物組合せ
WO2008079256A2 (en) Methods for treating nasal congestion in hypertensive or diabetic patients
TW200838524A (en) Methods for treating nasal congestion in hepatically impaired patients
Frew et al. Effects of 4-week treatment with low-dose budesonide (100 μg BID) from a novel inhaler AirmaxTM and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma
JP2003048834A (ja) 医薬組成物
MXPA99003936A (en) Composition, for the treatment of asthma, containing loratadine and a decongestant
JP2001511159A (ja) オキシムを含むシナプス機能障害の処置用医薬組成物
McDonald et al. Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction
Chuchalin et al. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler™) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer®) in children with persistent asthma
WO2004039408A1 (ja) 医薬組成物
AU2002329578B2 (en) Compositions for treatment of common cold
WO2002019995A2 (en) Pharmaceutical combination containing salmeterol and fluticasone
TW200838523A (en) Methods for treating nasal congestion in pediatric patients